Physician

Ali Alexandru Achira, M.D

According to 2025 Medicare claims, Ali Achira, M.D (NPI: 1427345065) practices endocrinology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is ALI ACHIRA MD PC (NPI: 1750895835; TIN: 813187965) and primary practice location at 48180-2755.

Achira's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 1,619 HCPCS/CPT codes, and received $103,588 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 7,998 prescription claims across 712 beneficiaries totaling $4,245,433 in drug costs, led by Ozempic (Semaglutide). DME data shows 177 claims. Open Payments data shows 88 records totaling $1,372. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $121,779 to $4,245,433. For DME billing, reported payments rose steadily, from $4,146 to $60,242.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	261	1,939	$103,961
2018	473	3,318	$201,920
2019	453	2,311	$175,159
2020	475	2,737	$181,847
2021	401	2,432	$158,430
2022	332	1,964	$117,598
2023	382	1,862	$116,012
2024	356	1,619	$103,588

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	111	574	$121,779
2016	80	551	$162,286
2017	169	1,478	$414,019
2018	270	3,342	$1,019,894
2019	225	1,705	$593,900
2020	293	3,623	$1,433,729
2021	428	4,709	$2,305,340
2022	536	6,436	$3,277,710
2023	694	8,788	$4,983,398
2024	712	7,998	$4,245,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	12	19	$372
2018	105	225	$11,411
2019	44	76	$1,270
2020	32	91	$5,819
2021	91	318	$45,477
2022	61	218	$28,874
2023	49	214	$33,888
2024	54	177	$53,225

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	94	94	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	227	510	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	70	82	$59
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	78	137	$29
82962	Blood glucose (sugar) test performed by hand-held instrument	141	287	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	863	36,266	$1,150,537
Jardiance	Empagliflozin	826	39,122	$743,410
Mounjaro	Tirzepatide	605	19,070	$687,969
Trulicity	Dulaglutide	475	15,192	$502,835
Farxiga	Dapagliflozin Propanediol	590	25,140	$465,571

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	32	105	$47,331
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	11	11	$2,387
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	12	$2,205
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	12	$797
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	25	$490

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$1,372	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Alexandru Achira, M.D?

Tedicare shows public-source Medicare data for Ali Alexandru Achira, M.D (NPI 1427345065), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Alexandru Achira, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Alexandru Achira, M.D?

Ali Alexandru Achira, M.D is linked to ALI ACHIRA MD PC (billing NPI 1750895835) in the available physician profile data.

Does Ali Alexandru Achira, M.D have Open Payments data?

Ali Alexandru Achira, M.D has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.